- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 277/52 - Atomes d'azote liés à des hétéro-atomes à des atomes de soufre, p. ex. sulfamides
Détention brevets de la classe C07D 277/52
Brevets de cette classe: 118
Historique des publications depuis 10 ans
|
7
|
11
|
11
|
14
|
12
|
7
|
5
|
5
|
7
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Xenon Pharmaceuticals Inc. | 193 |
11 |
| Step Pharma S.A.S. | 33 |
9 |
| Merck Sharp & Dohme LLC | 3732 |
7 |
| Vertex Pharmaceuticals Incorporated | 1630 |
4 |
| Chromocell Corporation | 47 |
3 |
| Dompé Farmaceutici S.p.A. | 278 |
3 |
| Eastern Virginia Medical School | 68 |
3 |
| Genzyme Corporation | 1314 |
3 |
| The Regents of the University of California, Santa Cruz | 18 |
3 |
| Thomas Jefferson University | 544 |
3 |
| Nodthera Limited | 40 |
3 |
| Bristol-myers Squibb Company | 4826 |
2 |
| Amgen Inc. | 4256 |
2 |
| Board of Regents, The University of Texas System | 5946 |
2 |
| President and Fellows of Harvard College | 6043 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2216 |
2 |
| Beth Israel Deaconess Medical Center, Inc. | 865 |
2 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 24 |
2 |
| Icagen, Inc. | 18 |
2 |
| Autres propriétaires | 48 |